ADMA Biologics Inc - Common Stock (NQ:ADMA)

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Action Lawsuit Deadline on August 10, 2026

August 10, 2026

From Faruqi & Faruqi, LLP

ADMA DEADLINE TOMORROW: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA

Performance

52-Week Range 52.5% below 52-week high

9.720

7.2152W Low 20.4652W High

1 Week 5.5% below 1-week high

9.251W Low 10.291W High

ADMA Biologics Inc - Common Stock (ADMA) traded between $7.21 and $20.46 over the past 52 weeks and last traded at $9.72, 52.5% below its 52-week high. Over the past week it ranged between $9.25 and $10.29.

Past 12 Months

-4.0%

+2.2%

+6.1%

+4.7%

-45.6%

-33.1%

1W -$0.40

1M +$0.21

3M +$0.56

6M +$0.44

YTD -$8.16

1Y -$4.81

ADMA was -33.1% over the past year, +4.7% over six months, -45.6% year to date, -4.0% in the last week.

12 Months vs Market

ADMA

-33.1%

DIA

+9.9%

SPY

+15.0%

QQQ

+23.7%

IWM

+15.4%

Over the past 12 months ADMA returned -33.1% versus DIA (Dow) +9.9%, SPY (S&P 500) +15.0%, QQQ (Nasdaq 100) +23.7% and IWM (Russell 2000) +15.4%.

Volume & Liquidity 1.07× 3-mo avg

Today 2,807,224 3-mo avg 2.6M

3.3M

3.1M

2.6M

3.9M

YTD

4.2M

4.0M

ADMA most recently traded 2,807,224 shares against a 3-month average daily volume of 2.6M.

More News

August 09, 2026

ADMA Biologics 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA

August 07, 2026

From Kahn Swick & Foti, LLC

ADMA BIOLOGICS CLASS ACTION DEADLINE AUGUST 10th: Bragar Eagel & Squire, P.C. Urges ADMA Biologics, Inc. Stockholders to Contact the Firm Regarding Their Rights Before August 10th

ADMA Biologics (NASDAQ:ADMA) Shares Slide as Q2 Results Miss Estimates ↗

August 05, 2026

Via Chartmill

August 07, 2026

From Bragar Eagel & Squire

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

August 07, 2026

Via Newsfile

ADMA Biologics Deadline: Rosen Law Firm Encourages ADMA Biologics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA

August 07, 2026

From The Rosen Law Firm, P.A.

ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA

August 07, 2026

From SkyMedia, LLC

ADMA BIOLOGICS DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA

August 06, 2026

ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with SBS Law

August 06, 2026

From Schall, Brown & Schwartz LLP

ADMA Biologics Q2 Earnings Call Highlights ↗

August 05, 2026

Via MarketBeat

ADMA Biologics Reports Second Quarter 2026 Financial Results and Provides Business Update

August 05, 2026

From ADMA Biologics, Inc.

ADMA Biologics (ADMA) Shareholder Alert: Kehoe Law Firm Investigates Potential Fiduciary Duty Breaches

August 05, 2026

Via Newsfile

DEADLINE NEXT WEEK: Berger Montague Advises ADMA Biologics, Inc. (NASDAQ: ADMA) Investors to Contact the Firm Before August 10, 2026

August 05, 2026

From Berger Montague

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

August 04, 2026

From Kahn Swick & Foti, LLC

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ADMA Biologics, Inc. of Class Action Lawsuit and Upcoming Deadlines – ADMA

August 04, 2026

From Pomerantz LLP

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against ADMA Biologics, Inc. (ADMA)

August 04, 2026

From Bernstein Liebhard LLP

ADMA BIOLOGICS CLASS ACTION DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Urges ADMA Biologics, Inc. Stockholders to Contact the Firm Regarding Their Rights Before August 10th

August 03, 2026

From Bragar Eagel & Squire

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

August 03, 2026

Via Newsfile

ADMA BIOLOGICS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA

August 03, 2026

ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with SBS Law

August 03, 2026

From Schall, Brown & Schwartz LLP

ADMA DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA

July 31, 2026

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

July 31, 2026

Via Newsfile

ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C.

July 31, 2026

From Lowey Dannenberg, P.C.